Details for Patent: 7,381,427
✉ Email this page to a colleague
Summary for Patent: 7,381,427
| Title: | Seborrheic keratosis treatment |
| Abstract: | The subject of the present invention is seborrheic keratosis removal and prevention utilizing safe dependable effective biocompatible treatments with no scarring, bleeding, burning, freezing, shocking, and hypopigmentation or hyperpigmentation. |
| Inventor(s): | Margaret Ancira, Mickey Miller |
| Assignee: | MILLER MICKEY MR , Aclaris Therapeutics Inc |
| Application Number: | US10/684,136 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Dosage form; |
| Patent landscape, scope, and claims: |
More… ↓ |
Drugs Protected by US Patent 7,381,427
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 7,381,427
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Austria | 397452 | ⤷ Start Trial | |||
| Australia | 2007203283 | ⤷ Start Trial | |||
| Brazil | 0207163 | ⤷ Start Trial | |||
| Canada | 2437823 | ⤷ Start Trial | |||
| China | 100508990 | ⤷ Start Trial | |||
| China | 1501804 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
